Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by UGT1A1 Status in Patients With Locally Advanced Rectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by UGT1A1 Status in Patients With Locally Advanced Rectal Cancer
J. Clin. Oncol 2020 Oct 29;[EPub Ahead of Print], J Zhu, A Liu, X Sun, L Liu, Y Zhu, T Zhang, J Jia, S Tan, J Wu, X Wang, J Zhou, J Yang, C Zhang, H Zhang, Y Zhao, G Cai, W Zhang, F Xia, J Wan, H Zhang, L Shen, S Cai, Z ZhangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.